5-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride
97%
- Product Code: 119841
CAS:
215788-34-4
Molecular Weight: | 237.65 g./mol | Molecular Formula: | C₁₀H₁₁ClF₃N |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | 217.4°C | |
Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological disorders. Its trifluoromethyl group enhances the metabolic stability and bioavailability of the resulting compounds, making it valuable in drug development. Additionally, it is explored for its potential in creating ligands for receptor studies, aiding in the understanding of complex biochemical pathways. Its application extends to the development of novel therapeutic agents for conditions such as depression, anxiety, and other central nervous system-related diseases.
Product Specification:
Test | Specification |
---|---|
Appearance | White To Off-White Solid |
Purity (%) | 96.5-100 |
1 H Nmr Spectrum | Consistent With Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.025 | 10-20 days | $41.33 |
+
-
|
0.100 | 10-20 days | $80.78 |
+
-
|
0.500 | 10-20 days | $368.67 |
+
-
|
5-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological disorders. Its trifluoromethyl group enhances the metabolic stability and bioavailability of the resulting compounds, making it valuable in drug development. Additionally, it is explored for its potential in creating ligands for receptor studies, aiding in the understanding of complex biochemical pathways. Its application extends to the development of novel therapeutic agents for conditions such as depression, anxiety, and other central nervous system-related diseases.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :